Your browser doesn't support javascript.
loading
Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype.
Zheng, Ruifang; Fuda, Franklin; Gagan, Jeffrey R; Weinberg, Olga K; Koduru, Prasad; Cantu, Miguel; Ludwig, Kathleen; Truscott, Jamie M; Collins, Robert; Chung, Stephen; Madanat, Yazan F; Chen, Weina.
Afiliação
  • Zheng R; Departments of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Fuda F; Departments of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Gagan JR; Departments of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Weinberg OK; Departments of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Koduru P; Departments of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Cantu M; Departments of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Ludwig K; Departments of Pediatrics (Hematology and Oncology), University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Truscott JM; Departments of Pediatrics (Hematology and Oncology), University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Collins R; Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Chung S; Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Madanat YF; Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Chen W; Departments of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Leuk Res Rep ; 21: 100410, 2024.
Article em En | MEDLINE | ID: mdl-38273970
ABSTRACT
B/T mixed phenotype acute leukemia (MPAL) is a rare aggressive leukemia. Three cases of B/T MPAL were identified with comprehensive immunophenotypic, cytogenetic, and molecular studies. T-lineage predominant B/T MPAL shares a genetic signature with T-ALL whereas B/T lineage co-dominant B/T MPAL lacks such a T-ALL signature. All three patients were treated with lineage-matched-ALL therapy and alive at the last follow-up. Our study is the first to demonstrate molecular heterogeneity within B/T MPAL in a context of an immunophenotype of T-lineage versus B-lineage predominance. The implication of such a phenotype-genotype association on diagnostic classification is briefly discussed.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Leuk Res Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Leuk Res Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos